GEG Tech announces publication of a seminal study on topical mRNA delivery for skin regeneration.
This study opens the way to new applications of topical mRNA delivery in skin regeneration, advanced dermatology and regenerative beauty.
next-generation vaccines
Advances in vectorology and RNA delivery are opening a new chapter in vaccinology Can next-generation vaccines help close the gap between innovation and global health equity?In our new review published in Frontiers in Immunology — “GenIV vaccines: bridging innovation to equity in neglected tropical diseases” — we explore how fourth-generation vaccines (GenIV), including mRNA platforms, […]
This incredible technique restores sight to blind mice… and soon to humans?
Le Parisien, one of France’s leading daily newspapers, published yesterday a full-page report highlighting results obtained by our team in collaboration with the University of California – UC Irvine – in Professor Krzysztof Palczewski’s lab. These results demonstrate the restoration of vision in mice blind from birth, with the objective of developing precision gene therapies […]
À Saclay, l’incubateur de pointe de Servier cherche à attirer les start-up @La Tribune
La Tribune highlights our biotech company GEG-Tech, whose research laboratory is located in Saclay.The article notably reveals a technological partnership with Servier, France’s second-largest pharmaceutical group. GEG-Tech, a specialist in genetic engineering, is implementing its technology to strengthen the company’s drug screening and therapeutic innovation. The company announced an acceleration of its growth earlier this […]
Retinal gene therapy: Visual cycle restored in blind mice
Press Release January 20th, 2025 Retinal gene therapy: Visual cycle restored in blind mice University of California, Irvine and GEG Tech announce results paving the way for high-precision gene therapy Over the last few years, the field of gene editing witnessed a tremendous acceleration as new therapies were approved and treatment strategies started to make […]
Release of new mRNA vectors for prime & base editing
GEG Tech launches a series of collaborations with leading research institutions to enable high-precision gene therapy based on genome editing GEG Tech announces the release of a new mRNA vector technology, designed to deliver novel prime and base editing systems. Leading research institutions in the field of genome editing, including the Broad Institute of MIT […]
We moved our Lab facility at Spartners by Servier and Biolabs
Very proud and excited to join this beautiful lab which is at the forefront of technology, in the middle of the burgeoning Paris-Saclay scientific ecosystem. With great collaborative projects on the horizon ! What better way to start a new GEG-Tech chapter!
Innovative Nanoparticles for ex vivo and in vivo Genome Editing
Innovative Nanoparticles to deliver mRNA for Vaccination
European Society of Gene and Cell Therapy ESGCT 30th Annual Congress, Brussels
Nicolas Grandchamp will be at the European Society of Gene and Cell Therapy ESGCT 30th Annual Congress, October 24-27 2023, Brussels. He will take advantage of this congress to present our latest results concerning the use of our property mRNA delivery platforms in genome editing.